Results 101 to 110 of about 15,364 (179)

Efficacy and safety of dapsone in adult immune thrombocytopenia: a systematic review and meta-analysis. [PDF]

Eur J Med Res
Khan I, Qasim SA, Rath S, Mumtaz Malik H, Rehman S, Aleem S, Javaid H, Saleh AO, Halim SA, Kamil KA.   +9 more
europepmc   +1 more source

Infective endocarditis after splenectomy for ovarian cancer: a case report. [PDF]

BMC Surg
Ye L, Wang X, Zhao Q, Cheng X, Chen Y, Zhou B, Liu J, Ni J, Chen X.   +8 more
europepmc   +1 more source

Editorial: Thrombopoietin [PDF]

Blood, 1974
openaire   +1 more source

Eltrombopag for Refractory Immune Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: A Case Report. [PDF]

Int Med Case Rep J
Alsalman M.
europepmc   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients. [PDF]

Am J Hematol
Marques C, Moulis G, Roussotte M, Bonnotte B, Viallard JF, Graveleau J, Lobbes H, Costedoat-Chalumeau N, Deroux A, Gobert D, Dossier A, Gilardin L, Lambotte O, Dufrenoy M, Mahévas M, Michel M, Sève P, Godeau B.   +17 more
europepmc   +1 more source

Recurrent severe thrombocytopenia induced by anti-HER2 therapy in a breast cancer patient with an underlying immune disorder: a case report and literature review. [PDF]

Front Oncol
Wang B, Chen L, Tang Q.
europepmc   +1 more source

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial. [PDF]

Br J Haematol
Nakamura F, Ishiyama K, Suzuki R, Maruyama H, Onishi Y, Usuki K, Koh H, Takenaka K, Saiki R, Ogawa S, Matsumoto K, Takahashi T, Hosomichi K, Zaimoku Y, Yoshimura K, Matsumura I, Akashi K, Nakao S.   +17 more
europepmc   +1 more source

Optimization of thrombopoietin mimetic peptide fusion proteins with albumin-binding domain for enhanced bioactivity and extended half-life. [PDF]

Sci Rep
Ying J, Zheng Y, Xu X, Yang J, Hu A, Gao G.   +5 more
europepmc   +1 more source

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia? [PDF]

Res Pract Thromb Haemost
Al-Samkari H.
europepmc   +1 more source